Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.05.2022 | Case report

Nivolumab

Subacute cutaneous lupus erythematosus, hepatitis and pneumonitis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Diago A, et al. Subacute cutaneous lupus erythematosus induced by PD-1 Inhibitor therapy: two case reports and literature review. [Review]. Australasian Journal of Dermatology 62: e347-e349, No. 2, May 2021. Available from: URL: http://doi.org/10.1111/ajd.13538 Diago A, et al. Subacute cutaneous lupus erythematosus induced by PD-1 Inhibitor therapy: two case reports and literature review. [Review]. Australasian Journal of Dermatology 62: e347-e349, No. 2, May 2021. Available from: URL: http://​doi.​org/​10.​1111/​ajd.​13538
Metadaten
Titel
Nivolumab
Subacute cutaneous lupus erythematosus, hepatitis and pneumonitis: 2 case reports
Publikationsdatum
01.05.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-15203-7

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Immunoglobulin G

Case report

Clozapine

Case report

Antiretrovirals